Nitric oxide and ocular blood flow in patients with IDDM

Diabetes

Volumn 46, Issue 4, 1997, Pages 653-658

  Schmetterer, Leopold ^a,b,c   Findl, Oliver ^a   Fasching, Peter ^c   Ferber, Wolfgang ^a   Strenn, Karin ^a   Breiteneder, Helene ^a   Adam, Hiltrud ^a   Eichler, Hans Georg ^a   Wolzt, Michael ^a  

^a Department of Clinical Pharmacology ^*

^b Institute for Medical Physics   (Austria)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ARGININE; C PEPTIDE; GLUCOSE; INSULIN; N(G) METHYLARGININE; NITRATE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ADULT; ARTICLE; BLOOD FLOW VELOCITY; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC RETINOPATHY; DIASTOLIC BLOOD PRESSURE; DOPPLER ECHOGRAPHY; EYE BLOOD FLOW; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INTERFEROMETRY; MALE; MEAN ARTERIAL PRESSURE; MICROALBUMINURIA; OPHTHALMIC ARTERY; PRIORITY JOURNAL; PULSE RATE; SYSTOLIC BLOOD PRESSURE;

EID: 0030903262     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.46.4.653     Document Type: Article

References (40)

1. Calver A, Collier J, Vallance P: Inhibition and stimulation of nitric oxide synthesis in the human forearm arterial bed of patients with insulin-dependent diabetes. J Clin Invest 90:2548-2554, 1992
2. G-nitro L-arginine methyl ester on regional haemodynamics in conscious rats with streptozotocin-induced diabetes mellitus. Br J Pharmacol 103:1321-1326, 1991
3. Komers R, Allen TJ, Cooper ME: Role of endothelium-derived nitric oxide in the pathogenesis of the renal hemodynamic changes of experimental diabetes. Diabetes 43:1190-1197, 1994
4. G-nitro-L-arginine methyl ester in streptozotocin-induced diabetes mellitus. Br J Pharmacol 106:1035-1040, 1992
5. McVeigh GE, Brennan GM, Johnston GD, McDermott BJ, McGrath LT, Henry WR, Andrews JW, Hayes JR: Impaired endothelium-dependent and independent vasodilation in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 35:771-776, 1992
6. Moncada S, Radomski MW, Palmer RMJ: Endothelium derived relaxing factor: identification as nitric oxide and role in the control of vascular tone and platelet function. Biochem Pharmacol 37:2495-2501, 1988
7. Gardiner SM, Compton AM, Bennet T, Palmer RMJ, Moncada A: Control of regional blood flow by endothelium-derived nitric oxide. Hypertension 15:486-492, 1990
8. Haefliger IO, Flammer J, LüscherTF: Nitric oxide and endothelin-1 are important regulators of human ophthalmic artery. Invest Ophthalmol Vis Sci 33:2340-2343, 1992
9. Deussen A, Sonntag M, Vogel R: L-arginine derived nitrous oxide: a major determinant of uveal blood flow. Exp Eye Res 57:129-134, 1993
10. Mann RM, Riva CE, Stone RA, Barnes GE, Cranstoun S: Nitric oxide and choroidal blood flow regulation. Invest Ophthalmol Vis Sci 36:925-930, 1995
11. Schmetterer L, Krejcy K, Kastner J, Wolzt M, Gouya G, Lexer F, Monitzer B, Schütz W, Fercher AF, Eichler HG: The effect of systemic nitric oxide-synthase inhibition on ocular fundus pulsations in man. Exp Eye Res. In press
12. Haefliger IO, Meyer P, Flammer J, Lüscher TF: The vascular endothelium as a regulator of the ocular circulation: a new concept in ophthalmology? Surv Ophthalmol 39:123-132, 1994
13. Schmetterer L, Lexer F, Unfried C, Sattmann H, Fercher AF: Topical measurement of fundus pulsations. Opt Eng 34:711-716, 1995
14. Lieb WE, Cohen SM, Merton DA, Shields JA, Mitchell DG, Goldberg BB: Color Doppler imaging of the eye and the orbit. Arch Ophthalmol 109:527-531, 1991
15. Schmetterer L, Wolzt M, Salomon A, Rheinberger A, Unfried C, Zanaschka G, Fercher AF: The effect of isoproterenol, phenylephrine and sodium nitroprusside on fundus pulsations in healthy volunteers. Br J Ophthalmol 80:217-223, 1996
16. The Diabetic Retinopathy Study Group: A modification of the Airlie House classification of diabetic retinopathy. Invest Ophthalmol Vis Sci 21:211-226, 1981
17. Klein BE, Davis MD, Segal P, Long JA, Harris A, Haug GA, Magli YL, Syrjala S: Diabetic retinopathy: assessment of severity and progression. Ophthalmology 91:10-17, 1984
18. Fasching P, Derfler K, Maca T, Kurzemann S, Howorka K, Schneider B, Zirm M, Waldhäusl W: Feasibility and efficiacy of intensive insulin therapy in type 1 diabetes mellitus in primary care. Diabetic Med 11:836-842, 1994
19. Bode-Böger SM, Böger RH, Creutzig A, Tsikas D, Gutzki FM, Alexander K, Frölich JC: L-arginine infusion decreases peripheral arterial resistance and inhibits platelet aggregation in healthy subjects. Clin Sci 87:303-310, 1994
20. Hishikawa K, Nakaki T, Tsuda M, Esumi H, Ohshima H, Suzuki H, Saruta T, Kato R: Effect of L-arginine administration on hemodynamics and nitric oxide release in man. Jpn Heart J 33:41-48, 1992
21. Schmetterer L, Kemmler D, Breiteneder H, Alschinger C, Koppensteiner R, Lexer F, Fercher AF, Eichler HG, Wolzt M: A randomized, placebo-controlled, double blind cross over study of the effect of pentoxifylline on ocular fundus pulsations. Am J Ophthalmol 121:169-176, 1996
22. Jilma B, Kastner J, Mensik C, Hildebrand J, Vondrovec B, Krejcy K, Wagner O, Eichler HG: Sex differences in nitric oxide production. Life Sci 58:469-476, 1996
23. Kharitonov SA, Yates D, Robbins RA, Logan-Sinclair R, Shinebourne EA, Barnes PJ: Increased nitric oxide in exhaled air of asthmatic patients. Lancet 343:133-135, 1994
24. Kharitonov SA, Lubec G, Lubec B, Hjelm M, Barnes PJ: L-arginine increases exhaled nitric oxide in normal human subjects. Clin Sci 88:135-139, 1995
25. Roth EA, Steininger R, Winkler S, Längte F, Grünberger T, Függer R, Mühlbacher F: L-arginine deficiency after liver transplantation as an effect of arginase efflux from the graft. Transplantation 57:665-669, 1994
26. Smulders RA, Stehouwer CD, Olthof CG, van Kamp GJ, Teerlink T, de Vries JM, Donker JM: Plasma endothelin levels and vascular effects of intravenous L-arginine infusion in subjects with uncomplicated insulin-dependent diabetes mellitus. Clin Sci 87:37-43, 1994
27. MacAllister RJ, Calver AL, Collier J, Edwards MCB, Herreros B, Nussey SS, Vallance P: Vascular and hormonal response to arginine: provision of substrate for nitric oxide or non-specific effect? Clin Sci 89:183-190, 1995
28. Fasching P, Ratheiser K, Nowotny P, Kurzemann S, Parzer S, Waldhäusl W: Insulin production following intravenous glucose, arginine, and valine: different pattern in patients with impaired glucose tolerance and non-insulin dependent diabetes mellitus. Metabolism 43:385-389, 1994
29. Anderson EA, Mark AL: The vasodilator action of insulin: implications for the insulin hypothesis of hypertension. Hypertension 21:136-141, 1993
30. Corbett JA, Tilton RG, Chang K, Hasan KS, Ido Y, Wang JL, Sweetland MA, Lancaster JR, Williamson JR, McDaniel ML: Aminoguanidine, a novel inhibitor of nitric oxide formation, prevents diabetic vascular dysfunction. Diabetes 41:552-556, 1992
31. Hasan KS, Chang K, Allison W, Santiago JV, Tilton RG: Aminoguanidine-induced increases in mean arterial blood pressure are suppressed in diabetic rats and normalized by sorbinil (Abstract). Diabetes 41 (Suppl. 1):195A, 1992
32. Tilton RG, Chang K, Hasan KS, Smith SR, Petrash JM, Misko TP, Moore WM, Currie MG, Corbett JA, McDaniel ML, Williamson JR: Prevention of diabetic vascular dysfunction by guanidines: inhibition of nitric oxide synthase versus advanced gycation end-product formation. Diabetes 42:221-232, 1993
33. G-monomethyl-L-arginine on the onset of diabetes in the spontaneously diabetic BB rat. Diabetes 44:360-364, 1995
34. Kharitonov SA, Yates DH, Robbins RA, Thomas PS, Barnes PJ: Corticosteroids decrease exhaled nitric oxide (Abstract). Am J Resp Crit Care Med 149:A201, 1994
35. Grunwald JE, Riva CE, Baine J, Brucker AJ: Total retinal volumetric blood flow rate in diabetic patients with poor glycemic control. Invest Ophthalmol Vis Sci 33:356-363, 1992
36. Goebel W, Lieb WE, Ho A, Sergott RC, Farhoumand R, Grehn F: Color Doppler imaging: a new technique to assess orbital blood flow in patients with diabetic retinopathy. Invest Ophthalmol Vis Sci 34:864-870, 1995
37. Grunwald JE, Brucker AJ, Grunwald SE, Riva CE: Retinal hemodynamics in proliferative diabetic retinopathy. Invest Ophthalmol Vis Sci 34:66-71, 1993
38. Mendivil A, Cuartero AV, Mendivil MP: Ocular blood flow velocities in patients with proliferative diabetic retinopathy and healthy volunteers. Br J Ophthalmol 79:413-416, 1995
39. Schmetterer L, Wolzt M, Lexer F, Alschinger C, Gouya G, Zanaschka G, Fassolt A, Eichler HG, Fercher AF: The effect of hyperoxia and hypercapnia on fundus pulsations in the macular and the optic disc region. Exp Eye Res 61:685-690, 1995
40. Harris A Williamson TH, Martin B, Shoemaker JA, Sergott RC, Spaeth GL, Katz JL: Test/retest reproducibility of color Doppler imaging assessment of blood flow velocity in orbital vessels. J Glaucoma 4:281-286, 1995